Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating on Altus Power with Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Finances
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 15, 2024, analyst Justin Clare from Roth MKM reiterated his Buy rating on Altus Power (NYSE: AMPS) and adjusted the price target from $8 to $7. Clare’s optimistic perspective on Altus Power’s stock remains unchanged, with a revised target price reflecting his ongoing confidence in the company’s performance.

AMPS Stock Plummets by 18.18% on March 15, 2024: Investors Advised to Proceed with Caution

On March 15, 2024, AMPS stock experienced a significant drop in price, opening at $5.14, which was $0.80 lower than its previous close. Throughout the day, the stock continued to decline, ultimately dropping by $1.08, or 18.18%, since the market last closed. Investors who hold AMPS shares may be feeling the impact of this price drop, as their investments have decreased in value. It is important for investors to closely monitor the stock’s performance and consider their options moving forward. Individual stock performances can be influenced by a variety of factors, including market conditions, company news, and overall economic trends. Overall, the performance of AMPS on March 15, 2024, highlights the volatility and unpredictability of the stock market. Investors should proceed with caution and seek guidance from financial advisors if needed to navigate these fluctuations effectively.

AMPS Stock Performance Analysis: Strong Yearly Growth, Quarterly Decline

On March 15, 2024, AMPS stock had a mixed performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $101.16 million for the past year, showing a significant increase of 40.9% compared to the previous year. However, the total revenue for the last quarter was $45.08 million, which reflects a decrease of 3.08% compared to the previous quarter.

In terms of net income, AMPS reported a net income of $55.00 million for the past year, representing a substantial increase of 845.74% compared to the previous year. However, the net income for the last quarter was $5.30 million, showing a decrease of 21.9% compared to the previous quarter.

Earnings per share (EPS) for AMPS were $0.35 for the past year, indicating a significant increase of 834.39% compared to the previous year. However, the EPS for the last quarter was $0.03, reflecting a decrease of 22.48% compared to the previous quarter.

Overall, the financial performance of AMPS on March 15, 2024, showed a mixed picture with strong year-over-year growth in total revenue, net income, and EPS, but a decline in these metrics compared to the previous quarter. Investors and analysts may need to closely monitor the company’s financial performance in the coming quarters to assess its long-term growth prospects and stock performance.

Tags: AMPS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Real Estate Investment Stock Market Today

Revolutionizing Real Estate NARs Historic Agreement to Reduce Commissions and Settle Lawsuits

Analyst Reiterates Positive Outlook on Evolent Health with Slight Price Target Adjustment

Finance_Capitalistic

Piper Sandler Reiterates Neutral Rating on Solo Brands Lowers Price Target

Recommended

Cardano Stock

Cardano at a Crossroads: Navigating Critical Support Levels Amid Major Developments

3 months ago
Tesla Stock

Tesla Stock: Musk’s $30B Payday Amid Customer Exodus

6 months ago
Oxford Lane Capital Stock

Oxford Lane Capital Implements Strategic Overhaul with Reverse Split and Buybacks

5 months ago
Ciena Stock

Ciena Shares Hit Record Peak Amid AI Infrastructure Surge

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Trending

DroneShield Stock
Analysis

DroneShield Shares Face Headwinds Despite Record Performance

by Jackson Burston
February 8, 2026
0

A significant disconnect has emerged for DroneShield Ltd. The counter-drone technology company posted explosive growth for fiscal...

Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead
  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com